A company that’s been working on meat growing technology in Columbia, Missouri, wants to relocate to the Brooklyn Army Terminal. CEO Andre Forgacs said that while biotech in the Bay Area is more mature, New York is more exciting. It’s not guranteed that his company, Modern Meadow, will come here, though. The hurdles that remain to be jumped (including genrous tax breaks) are detailed in Crain’s:
New York has long been where researchers started companies before moving them to Silicon Valley, Boston or San Diego—the top three areas for biotech venture-capital financing, and where there are plenty of experienced biotech executives and fully equipped lab space is cheap.
But in the past few years, the city and private groups have been focused on making New York a center for biotech just as it has become one for consumer tech. And those efforts have been speeding up in recent months.
[Crain’s]
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.